Prognostic impact of cancer history in patients undergoing transcatheter mitral valve repair.

ABSTRACT:

Background

History of cancer is common in patients undergoing transcatheter mitral valve repair (TMVR).

Objectives

Aim was to examine the impact of cancer history on outcomes after TMVR.

Methods

In patients of a monocentric prospective registry of TMVR history of cancer was retrospectively assessed from records. Associations with 6-week functional outcomes and clinical outcomes during a median follow-up period of 594 days were examined.

Results

Of 661 patients (mean age 79 years; age-range 37-101 years; 56.1% men), 21.6% had a history of cancer with active disease in 4.1%. Compared with non-cancer patients, cancer patients had a similar procedural success rate (reduction of mitral regurgitation to grade 2 or lower 91.6% vs. 88%; p = 0.517) and similar relevant

SUBMITTER: Kalkan A 

PROVIDER: S-EPMC10808190 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature